Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Cancer|April 30, 2008
Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancerZhong Zheng, Xueli Li, Michael J Schell, et al.
Academic Radiology|April 17, 2007
Comparison of three methods to increase knowledge about breast cancer and breast cancer screening in screening mammography patientsDag Pavic, Michael J Schell, Ria D Dancel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysisTawee Tanvetyanon, Lary A Robinson, Michael J Schell, et al.
American Journal of Epidemiology|February 19, 2025
Determining the threshold time in restricted mean survival time analysis for two group comparisons with applications in clinical and epidemiology studiesGang Han, Michael J Schell, Matthew Lee Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancerMark A Titus, Christopher W Gregory, O Harris Ford, et al.
Scientific Reports|June 20, 2018
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear TranslocationThomas B Davis, Mingli Yang, Michael J Schell, et al.
Cancer|October 27, 2011
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysisGeorge R Simon, Michael J Schell, Mubeena Begum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 19, 2025
A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint InhibitorsNathan H Parker, Jairo D Ramos, Ahmad A Tarhini, et al.
Academic Radiology|June 18, 2003
Factors predicting successful needle-localized breast biopsyPage E Abrahamson, Larry A Dunlap, M Ahinee Amamoo, et al.
Oncotarget|February 1, 2019
Green tea extract for prevention of prostate cancer progression in patients on active surveillanceNagi B Kumar, Shohreh I Dickinson, Michael J Schell, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Cancer|April 30, 2008
Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancerZhong Zheng, Xueli Li, Michael J Schell, et al.
Academic Radiology|April 17, 2007
Comparison of three methods to increase knowledge about breast cancer and breast cancer screening in screening mammography patientsDag Pavic, Michael J Schell, Ria D Dancel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysisTawee Tanvetyanon, Lary A Robinson, Michael J Schell, et al.
American Journal of Epidemiology|February 19, 2025
Determining the threshold time in restricted mean survival time analysis for two group comparisons with applications in clinical and epidemiology studiesGang Han, Michael J Schell, Matthew Lee Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2005
Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancerMark A Titus, Christopher W Gregory, O Harris Ford, et al.
Scientific Reports|June 20, 2018
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear TranslocationThomas B Davis, Mingli Yang, Michael J Schell, et al.
Cancer|October 27, 2011
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysisGeorge R Simon, Michael J Schell, Mubeena Begum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 19, 2025
A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint InhibitorsNathan H Parker, Jairo D Ramos, Ahmad A Tarhini, et al.
Academic Radiology|June 18, 2003
Factors predicting successful needle-localized breast biopsyPage E Abrahamson, Larry A Dunlap, M Ahinee Amamoo, et al.
Oncotarget|February 1, 2019
Green tea extract for prevention of prostate cancer progression in patients on active surveillanceNagi B Kumar, Shohreh I Dickinson, Michael J Schell, et al.
Pageof 16